Identification of Novel Protein Expression Changes Following Cisplatin Treatment and Application to Combination Therapy.

J Proteome Res 2017 11 29;16(11):4227-4236. Epub 2017 Sep 29.

Department of Medicine, ‡Committee on Clinical Pharmacology and Pharmacogenomics, ∥Ben May Department for Cancer Research; ⊥Committee on Genetics, Genomics and Systems Biology; #The Institute for Genomics and Systems Biology; ∇Committee on Cancer Biology; and □Department of Human Genetics, The University of Chicago , Chicago, Illinois 60637, United States.

Determining the effect of chemotherapeutic treatment on changes in protein expression can provide important targets for overcoming resistance. Due to challenges in simultaneously measuring large numbers of proteins, a paucity of data exists on global changes. To overcome these challenges, we utilized microwestern arrays that allowed us to measure the abundance and modification state of hundreds of cell signaling and transcription factor proteins in cells following drug exposure. HapMap lymphoblastoid cell lines (LCLs) were exposed to cisplatin, a chemotherapeutic agent commonly used to treat testicular, head and neck, non-small cell lung, and gynecological cancers. We evaluated the expression of 259 proteins following 2, 6, and 12 h of cisplatin treatment in two LCLs with discordant sensitivity to cisplatin. Of these 259 proteins, 66 displayed significantly different protein expression changes (p < 0.05). Fifteen of these proteins were evaluated in a second pair of LCLs with discordant sensitivities to cisplatin; six demonstrated significant differences in expression. We then evaluated a subset of 63 proteins in a second set of LCLs with discordant sensitivity, and 40% of those that were significant in the first pair were also significant in the second part with concordant directionality (p < 0.05). We functionally validated one of the top proteins identified, PDK1, and demonstrated a synergistic relationship between cisplatin and a PDK1 inhibitor in multiple lung cancer lines. This study highlights the potential for identifying novel targets through an understanding of cellular changes in protein expression and modification following drug treatments.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jproteome.7b00576DOI Listing
November 2017
29 Reads

Publication Analysis

Top Keywords

protein expression
16
lcls discordant
12
expression changes
8
259 proteins
8
discordant sensitivity
8
cisplatin treatment
8
changes protein
8
proteins
7
cisplatin
6
expression
6
changes
5
cell lines
4
exposure hapmap
4
lymphoblastoid cell
4
hapmap lymphoblastoid
4
lcls
4
synergistic relationship
4
lcls exposed
4
demonstrated synergistic
4
chemotherapeutic agent
4

Similar Publications